Imagine the need for agriculture being removed completely from the cannabis supply chain.

Cellibre’s vision is to leverage biology to make products more sustainable, efficiently and reliably across industries by employing the multidisciplinary science known as cellular agriculture. We leverage our expertise in cellular agriculture to turn cells into specialized, sustainable factories for the manufacture of globally significant products at scale.

Cells are inherently superior producers of products for a variety of reasons. First, nature’s machinery can conduct complex reactions at nanoscale precision that are difficult and, in some cases, impossible to achieve by any other means. This ability leads to improved quality and consistency over many legacy manufacturing processes and enable the potential to develop completely novel products. Next, cells copy themselves through cellular division which serves to multiple their natural brick and mortar infrastructure, often with minimal nutrients. This means that production scales itself. In addition, cells repair themselves. Cells have natural machinery that reacts when cell production is impaired to repair the damaged parts and return to regular course. This translates into lower maintenance costs and less downtime. Lastly, cell-based production is uniquely sustainable. Cells very efficiently convert inputs, typically low cost media, into high-value products. In addition, byproducts created as a resulted of bioproduction are generally non-toxic because harmful substances would terminate the cells and stop production of all materials, including the toxins themselves.

Cellibre's strategic focus is deploying its expertise in cellular agriculture to revolutionize the way cannabis extracts and cannabinoid-based medicines are sourced, produced and consumed. The resultant outputs from the bio-based manufacture of any cannabinoid (including minor cannabinoids) will be high-quality, sustainable and specific cannabinoids for use across applications. The significant deficiencies throughout the current cannabinoid supply chain, the resource requirements in the agricultural process and the evolving regulatory environment globally provide Cellibre an immense opportunity to disrupt a $50+ billion market via the production of high-quality, sustainable, specific and pure, medical-grade natural products.

Learning Objectives: 

1. What is cellular agriculture and the science of synthetic biology
2. Why is fermentation an advantaged method for the production of cannabis extracts on virtually all metrics